Fidasimtamab (Synonyms: IBI-315; BH2950) |
| Catalog No.GC69111 |
Fidasimtamab (IBI-315; BH2950) es un anticuerpo biespecífico recombinante de IgG1 humano que se dirige, une e inhibe simultáneamente HER2 y PD-1 y sus vías de señalización aguas abajo, conectando células T que expresan PD-1 con células tumorales que expresan HER2. Fidasimtamab tiene potencial actividad inmunosupresora y antitumoral.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2377419-89-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Fidasimtamab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Fidasimtamab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *